Salvatore Vanchieri

salvatore.vanchieri@lw.com

+1.212.906.4605

Profile

Salvatore Vanchieri represents clients in a variety of complex corporate finance and capital markets transactions.

Salvatore draws on broad experience across financing structures and industries to advise issuers, private equity firms, and financial institutions on the full spectrum of US and cross-border financing transactions, including:

Preferred equity and holdco PIK financings
Initial public offerings (IPOs) and subsequent equity financings
Acquisition financings
Debt exchange offers and tender offers
Secured and unsecured high yield debt offering
Investment grade debt offerings
SEC related matters, corporate governance, and other general corporate matters

He understands the nuances that arise at the intersection of law and finance, and skillfully walks clients through every stage of a transaction, from initial structuring to deal execution. Salvatore guides issuers from early stages and helps companies prepare for key milestones, including IPOs, as well as navigate life as a public company.

Experience

Salvatore's experience includes advising:

Private Capital

Investors on a US$500 million preferred equity investment as part of a larger financing for the Zendesk leveraged buyout
Private investors on a US$660 million holdco note investment to finance acquisition by top tier Sponsor
Brookwood Partners on its US$150 million preferred equity financing
Odyssey Investment Partners on preferred equity financings in connection with a number of acquisitions, including Service Champions, Protective Industrial Products, and ProPharma Group
Press Ganey on its preferred equity financing

IPOs and Subsequent Equity and Equity Derivative Financings

Rivian on its US$11.9 billion IPO and its US$1.3 billion green convertible senior notes offering
Global-E on its US$375 million IPO and US$768 million secondary offering
Vita Coco on its US$172.5 million IPO
Sol-Gel Technologies on its follow-on equity and warrant offerings, and its at-the-market offering
Zentalis Pharmaceuticals on its US$190 million IPO and subsequent follow on offerings, registered direct offering and at-the-market offering
Teladoc on its US$180 million IPO
The underwriters on:
- Driven Brands’ US$200 million IPO and US$225 million secondary offering
- Outset Medical’s US$278 million IPO
- YETI Holdings’ US$304 million IPO and subsequent secondary offerings
- Roivant’s US$200 million follow on equity offering
- Achilles Therapeutics US$175.5 million IPO
- Landos Biopharma’s US$100 million IPO
- SS&C Technologies Holdings’ US$1.25 billion common stock offering
- Acushnet’s US$378 million IPO
- American Well’s US$850 million IPO

High Yield and Investment Grade Debt

Century Link Inc. in its US$1.25 billion senior secured notes offering
The initial purchasers on:
- Abercrombie & Fitch Management’s US$350 million senior secured notes offering
- Presidio’s US$800 million senior notes offering and subsequent tack-on notes offerings
- McDermott Technology (Americas)’s US$1.3 billion senior notes offering
- Cumberland Farms’ US$300 million senior notes offering
- Truck Hero’s US$335 million senior notes offering